Share This Link

While failure to adhere to the prophylactic acyclovir regimen increases the statistical probability of an outbreak, the missed doses alone do not mandate a surgical delivery. A cesarean is only indicated if the client presents with active lesions or prodromal symptoms at the time of labor. The nurse should perform a thorough physical assessment, but in the absence of clinical signs, a vaginal delivery remains the preferred and safe route.

The rupture of membranes with clear fluid is a normal physiological occurrence in active labor and does not indicate an HSV-related complication. If the fluid were meconium-stained or if the client had active lesions, the clinical priority would shift; however, 2 hours of rupture does not necessitate a cesarean in a stable client. The duration of membrane rupture is only a concern in HSV if active lesions are present, as the risk of ascending infection increases over time.

A history of a primary outbreak 5 years ago indicates that the client has recurrent HSV rather than a primary infection, but it is not a reason for surgical intervention today. The presence of maternal antibodies from a long-standing infection actually provides some passive protection to the fetus, lowering the transmission risk compared to a primary maternal infection. Only current clinical evidence of viral activity at 39 weeks would alter the planned route of delivery.

A scheduled cesarean section is not routinely required for clients with a history of HSV if they are asymptomatic at the onset of labor. Surgical delivery is reserved specifically for those presenting with active vesicular lesions or prodromal symptoms, such as burning or tingling, in the genital tract. Automatically scheduling a cesarean at 38 weeks without clinical evidence of an outbreak exposes the client to unnecessary surgical risks and contradicts evidence-based practice for managing recurrent HSV.

Frequent vaginal exams every 2 hours during labor are contraindicated because they increase the risk of introducing pathogens and may cause unnecessary trauma to the maternal tissues. In the context of HSV, exams should be limited to the minimum number necessary to assess cervical effacement and dilation. Excessive manipulation of the birth canal could potentially facilitate the transfer of the virus to the fetus if subclinical shedding is occurring, though the primary assessment for lesions is performed only once upon admission.

The use of internal fetal scalp electrodes is strictly avoided in clients with a history of genital herpes unless absolutely necessary and in the absence of lesions. Any procedure that breaks the fetal integumentary barrier provides a direct portal of entry for the virus, significantly increasing the risk of neonatal herpes simplex infection. External monitoring is the preferred method for assessing fetal heart rate patterns to maintain the integrity of the infant's skin and prevent iatrogenic viral inoculation.

The client does not need to stop breastfeeding as long as there are no herpetic lesions present on the breasts. HSV-1 is not transmitted through breast milk itself; rather, transmission occurs through direct contact with active vesicles. The mother should be encouraged to continue lactation to provide the infant with passive immunity, provided she adheres to strict hand hygiene and covers the oral lesion.

Applying diaper cream (typically containing zinc oxide) to an oral herpes lesion is not an evidence-based treatment and may lead to secondary contamination of the product. Maternal lesions should be treated with appropriate antiviral creams or oral medications like acyclovir as prescribed by a healthcare provider. Furthermore, using a product intended for the infant on a maternal infection increases the risk of fomite transmission to the newborn.

It is absolutely unsafe to kiss a newborn anywhere when an active orolabial lesion is present, regardless of whether the lesion is touched. The virus can be present in saliva and on the surrounding skin through asymptomatic shedding, making any oral contact extremely high-risk. Neonatal herpes acquired through kissing can lead to devastating encephalitis or "kiss of death" syndromes, which carry a high mortality rate.

Penicillin G is a bactericidal antibiotic that acts by inhibiting the synthesis of the bacterial cell wall. It is the treatment of choice for neonatal syphilis but has zero efficacy against viral pathogens like the herpes simplex virus. Administering an antibiotic for a suspected viral viraemia would be a diagnostic and therapeutic error that fails to address the underlying cause of the neonate's clinical deterioration.

Spiramycin is a macrolide antibiotic used primarily in the treatment of maternal toxoplasmosis to reduce the risk of vertical transmission to the fetus. It does not possess antiviral properties and is not indicated for the management of the herpes simplex virus. Furthermore, it is generally administered to the mother during pregnancy rather than to the newborn as a primary treatment for acute disseminated viral disease.

Varicella-zoster immune globulin (VZIG) provides passive immunity specifically against the varicella-zoster virus (chickenpox). While varicella is also a member of the Herpesviridae family, VZIG does not contain the specific antibodies required to neutralize the herpes simplex virus (HSV-1 or HSV-2). Using VZIG for an HSV infection is an inappropriate use of blood products and would provide no protection against the disseminated viral replication occurring in the infant.